Genome-wide epigenomic profiling for biomarker discovery

Area of Science:

• Epigenetics and Genomics
• Biomarker Discovery
• Personalized Medicine

Background:

• Epigenetic alterations (DNA methylation, histone modifications, chromatin structure) are key in many diseases.
• Traditional epigenomic profiling requires large cell numbers, limiting clinical sample analysis.
• Cellular heterogeneity in clinical samples complicates genome-wide biomarker discovery.

Purpose of the Study:

• To review current genome-wide epigenomic profiling technologies and their miniaturization.
• To evaluate these technologies for future epigenetic biomarker discovery.
• To focus on compatibility with clinical sample preservation and automation for high throughput.

Main Methods:

• Overview of miniaturized genome-wide epigenomic profiling technologies.
• Discussion of technologies compatible with single-cell readout: Bisulfite sequencing, ChIP-Seq, DNaseI-Seq/ATAC-Seq, 4C-Seq, and HiC-Seq.
• Evaluation of technological advances enabling single-cell epigenomic analysis.

Main Results:

• Significant progress in miniaturizing epigenomic profiling assays to single-cell level.
• All major genome-wide profiling technologies are now scalable for single-cell analysis.
• These advancements facilitate large-scale epigenetic biomarker screens.

Conclusions:

• Miniaturized epigenomic profiling holds promise for disease diagnosis, prognosis, and stratification.
• Compatibility with clinical sample preservation and automation are key for clinical application.
• Epigenetic biomarker discovery is enhanced by scalable, single-cell epigenomic technologies.